Physician profile
Frederick J Tomassi
NPI 1063404937
$4,189.73
in general payments reported to CMS, 2019-2025
31 companies · $626 in 2025
The $626 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $409 · 2020: $340 · 2021: $910 · 2022: $876 · 2023: $565 · 2024: $464 · 2025: $626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,654.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,430.08 | 2019-2025 | Grafix Pl, Stravix Pl, Stravix |
| Organogenesis INC. | $698.76 | 2019-2025 | Puraply Wound Matrix, Affinity, Apligraf |
| Horizon Therapeutics Plc | $324.13 | 2019-2023 | Krystexxa |
| Bioventus LLC | $259.75 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Boston Scientific Corporation | $177.58 | 2021-2022 | |
| Integra Lifesciences Corporation | $172.25 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Averitas Pharma INC. | $125.89 | 2023-2025 | Qutenza |
| Misonix INC | $102.23 | 2020-2021 | |
| Amgen INC. | $97.91 | 2024-2025 | Krystexxa |
| Medtronic, INC. | $97.84 | 2025 | Inceptiv |
| Kci USA, INC. | $68.17 | 2020 | |
| Paratek Pharmaceuticals, INC. | $67.01 | 2023-2024 | Nuzyra |
| Abbott Laboratories | $66.65 | 2019-2021 | |
| Stryker Corporation | $65.68 | 2020-2025 | Augment Injectable, Citrefix, 7 X 23mm Citrelock Implant |
| Polynovo North America LLC | $48.37 | 2022-2023 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nabriva Therapeutics, Plc | $48.08 | 2021 | |
| Treace Medical Concepts, INC. | $43.16 | 2025 | |
| Reprise Biomedical, INC. | $36.38 | 2025 | Miro 3d, Miro3d |
| Kerecis Limited | $33.83 | 2019-2022 | |
| Grt US Holding, INC. | $30.20 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $29.46 | 2025 | |
| Inari Medical, INC. | $28.26 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Osiris Therapeutics INC. | $24.12 | 2019 | |
| Radius Health, INC. | $20.82 | 2022 | |
| Hartmann USA, INC. | $15.45 | 2024 | Zetuvit Plus 10x10 P10 |
| Urgo Medical North America, LLC | $14.31 | 2025 | Urgoclean Ag |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.77 | 2021 | |
| Axogen | $13.22 | 2019 | |
| Advanced Oxygen Therapy INC. | $12.74 | 2022 | |
| Pfizer INC. | $12.64 | 2019 | |
| Merck Sharp & Dohme LLC | $10.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Tomassi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.